Poxel – diabetes drug development

Poxel is a biopharma company developing innovative drugs for metabolic diseases, in particular Type 2 diabetes.

Poxel – diabetes drug development

poxel

Continue reading

Calypso Biotech – auto-immune diseases

Calypso Biotech is a biotech company developing antibody therapies up to clinical proof-of-concept by leveraging its expertise in immunology and drug development. Calypso Biotech’s portfolio consists of two therapeutic antibody programs planned to reach the clinic by 2016-2017 against gastro-intestinal auto-immune syndromes such as Crohn’s and Refractory Celiac diseases.

Calypso Biotech – auto-immune diseases

calypso biotech Continue reading

BioMarin – therapies for rare genetic diseases

BioMarin is a biotech company focusing on the delivery of first-to-market therapies for patients with rare genetic diseases.

BioMarin – therapies for rare genetic diseases

Biomarin Continue reading